Compumedics Limited (ASX:CMP)

Compumedics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	50.96	49.72	42.41	37.76	35.74
Other Revenue	0.08	0.54	0.52	0.85	-
Revenue	51.04	50.26	42.92	38.61	35.74
Revenue Growth (YoY)	1.55%	17.10%	11.18%	8.02%	1.91%
Cost of Revenue	20.05	23.65	20.82	18.44	16.58
Gross Profit	30.99	26.61	22.11	20.17	19.16
Selling, General & Admin	29.14	21.14	19.66	15.13	14.38
Research & Development	1.13	5.74	5.46	4.06	4.39
Other Operating Expenses	-	-	-	-	-0.56
Operating Expenses	30.27	26.88	25.12	19.18	18.21
Operating Income	0.71	-0.27	-3.02	0.99	0.96
Interest Expense	-1.29	-0.74	-0.65	-0.4	-0.33
Currency Exchange Gain (Loss)	-0.02	-0.18	0.04	0.17	-0.81
EBT Excluding Unusual Items	-0.59	-1.19	-3.63	0.76	-0.18
Asset Writedown	-	1.67	-3.09	-	-
Other Unusual Items	-	-	-	0.94	0.96
Pretax Income	-0.59	0.48	-6.72	1.7	0.78
Income Tax Expense	0.68	0.82	-0.6	0.34	-0.22
Net Income	-1.27	-0.34	-6.12	1.36	1
Net Income to Common	-1.27	-0.34	-6.12	1.36	1
Net Income Growth	-	-	-	35.97%	-
Shares Outstanding (Basic)	182	177	177	177	177
Shares Outstanding (Diluted)	182	177	177	177	177
Shares Change (YoY)	2.57%	-	-	-	-
EPS (Basic)	-0.01	-0.00	-0.03	0.01	0.01
EPS (Diluted)	-0.01	-0.00	-0.03	0.01	0.01
EPS Growth	-	-	-	35.97%	-
Free Cash Flow	0.47	1.69	-0.88	2.67	1.16
Free Cash Flow Per Share	0.00	0.01	-0.01	0.01	0.01
Gross Margin	60.71%	52.94%	51.50%	52.25%	53.62%
Operating Margin	1.40%	-0.53%	-7.03%	2.56%	2.68%
Profit Margin	-2.49%	-0.67%	-14.26%	3.52%	2.79%
Free Cash Flow Margin	0.92%	3.36%	-2.04%	6.92%	3.25%
EBITDA	1.94	0.24	-2.6	1.5	1.48
EBITDA Margin	3.80%	0.47%	-6.05%	3.89%	4.13%
D&A For EBITDA	1.23	0.51	0.42	0.51	0.52
EBIT	0.71	-0.27	-3.02	0.99	0.96
EBIT Margin	1.40%	-0.53%	-7.03%	2.56%	2.68%
Effective Tax Rate	-	170.42%	-	20.08%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.